Literature DB >> 30238583

Atopic-like dermatitis after secukinumab injection: A case report.

Martina Burlando1, Emanuele Cozzani1, Roberto Russo1, Aurora Parodi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30238583     DOI： 10.1111/dth.12751

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  4 in total

1.  Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System.

Authors:  Yamin Shu; Yufeng Ding; Yanxin Liu; Pan Wu; Xucheng He; Qilin Zhang
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

Review 2.  Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases.

Authors:  Fumi Miyagawa
Journal:  Biomedicines       Date:  2022-06-23

3.  Palmoplantar pompholyx secondary to interleukin 17A inhibitor therapy for psoriasis: A case series.

Authors:  Melissa Peera; Annika Smith
Journal:  JAAD Case Rep       Date:  2021-04-20

4.  Atopic Dermatitis as a Paradoxical Effect of Secukinumab for the Treatment of Psoriasis.

Authors:  Eduardo V Mendes Roncada; Victoria Romanini Brambilla; Beatriz Freitas Filitto; Mariana Pirajá Genta; Marilda Ap M Morgado de Abreu
Journal:  Case Rep Dermatol       Date:  2021-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.